Patricia P. R.
- Country
- Spain
- Department
- Neurology Department
Research Overview
- Long-Term Safety and Tolerability of Atogepant for Migraine Prevention in Chronic or Episodic Migraine: A Phase 3, 156-Week Extension Study
- Efficacy and Safety Evaluation of Botulinum Toxin Type A in Preventing Episodic Migraine in Adults: A Randomized, Double-Blind, Placebo-Controlled Study
- Randomized, Double-Blind, Placebo-Controlled Trial of Galcanezumab in Adolescents Aged 12-17 with Chronic Migraine: REBUILD-2 Study
Data & Insights
Has run more than one trial at 182 of 341 partner sites.
Specializations
Neurovascular and Migraine Disorders
Clinical research activity includes acute ischemic stroke, transient ischemic attack, and broader cerebrovascular disease, alongside therapeutic work in migraine and chronic migraine.
- Stroke
- Acute ischemic stroke
- Migraine
- Chronic migraine
Interest also extends to neurological symptom control and prevention-oriented approaches in vascular neurology.
Neuroimmunology and Demyelinating Disease
The investigator is involved in studies of multiple sclerosis, relapsing multiple sclerosis, primary progressive multiple sclerosis, and secondary progressive multiple sclerosis, as well as autoimmune neurological conditions such as myasthenia gravis and chronic inflammatory demyelinating polyneuropathy.
- Multiple sclerosis
- Myasthenia gravis
- Chronic inflammatory demyelinating polyneuropathy
- Autoimmune neurological disease
Therapeutic activity includes immune-modulating strategies for inflammatory disorders affecting the nervous system.
Epilepsy and Seizure Disorders
Research involvement covers focal epilepsy, focal onset seizures, refractory status epilepticus, and broader developmental and epileptic encephalopathies across paediatric and adult populations.
- Epilepsy
- Focal onset seizures
- Refractory status epilepticus
- Developmental and epileptic encephalopathies
This area reflects a strong therapeutic focus on seizure control in difficult-to-manage neurological disease.
Neurodegenerative and Movement Disorders
Clinical trial activity includes Alzheimer’s disease, early Parkinson’s disease, idiopathic Parkinson disease, and amyotrophic lateral sclerosis, with additional interest in ataxia telangiectasia and other progressive neurological syndromes.
- Alzheimer’s disease
- Parkinson’s disease
- Amyotrophic lateral sclerosis
- Ataxia telangiectasia
The therapeutic landscape includes disease-modifying and symptom-focused approaches in progressive neurological conditions.
Rare Neurological and Neuromuscular Conditions
The investigator also participates in research on spinal muscular atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy, and tuberous sclerosis complex, extending to other uncommon disorders with neurological involvement.
- Spinal muscular atrophy
- Duchenne muscular dystrophy
- Facioscapulohumeral muscular dystrophy
- Tuberous sclerosis complex
These studies align with therapeutic development in rare diseases affecting motor function, neurology, and long-term disability.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.